Among the most discussed compounds in the healthy aging and longevity space, two names appear frequently:
- Urolithin A
- Resveratrol
Both have attracted interest from researchers and consumers interested in cellular health, mitochondrial biology, physical function, and healthy aging.
Because they are often discussed around similar goals, a common question is:
Is Urolithin A better than Resveratrol?
The evidence does not support a simple universal winner.
Urolithin A and Resveratrol are different compounds with different origins, mechanisms, and levels of human clinical evidence. Urolithin A research has focused heavily on mitochondrial quality control and mitophagy, while Resveratrol has been studied across a much broader range of biological pathways, including oxidative stress, metabolic signaling, and sirtuin-related mechanisms.
This guide compares what we currently know from human studies, where the evidence is still uncertain, and how the two compounds differ from a research perspective.
Key Takeaways
- Urolithin A and Resveratrol act through different but partly overlapping biological pathways.
- Urolithin A research is particularly associated with mitochondrial quality control and mitophagy.
- Resveratrol research has focused on a broader range of pathways including oxidative stress, metabolic signaling, AMPK, and sirtuin-related biology.
- Urolithin A has several human randomized trials, but the evidence base is still relatively small.
- Resveratrol has substantially more human research overall, but results are heterogeneous and do not establish it as a proven anti-aging treatment.
- Direct head-to-head human trials comparing Urolithin A with Resveratrol are lacking.
- There is insufficient high-quality human evidence to conclude that taking both together provides better outcomes than either compound alone.
- Neither supplement should be presented as a substitute for exercise, sleep, nutrition, medical care, or other established health practices.
Quick Answer: Urolithin A vs Resveratrol
If you’re comparing Urolithin A and Resveratrol, the main difference is their research focus.
Urolithin A has attracted attention because of its relationship with mitochondrial quality control, mitophagy, muscle endurance, and age-related cellular function.
Resveratrol is a polyphenol studied across a much broader range of biological pathways, including oxidative stress, metabolic regulation, inflammation, and cellular signaling.
However:
There is currently no high-quality human evidence showing that Urolithin A is universally better than Resveratrol—or that Resveratrol is universally better than Urolithin A.
The better scientific question is not “Which one wins?” but:
What outcome has each compound actually been studied for in humans?
What Is Urolithin A?
Urolithin A is a metabolite produced when certain gut microorganisms transform ellagitannins and ellagic acid, compounds found in foods such as pomegranates, walnuts, raspberries, and strawberries.
Not everyone produces the same amount of Urolithin A from food because production depends partly on gut microbiome composition.
A study comparing pomegranate-derived precursors with direct Urolithin A administration found substantial differences between natural Urolithin producers and non-producers, illustrating why individual microbiome composition matters. View the human study on PubMed.
Researchers have become particularly interested in Urolithin A because of its relationship with mitophagy, a cellular quality-control process involved in identifying and removing damaged mitochondria.
Human research has subsequently investigated Urolithin A in areas including:
- Mitochondrial biomarkers
- Muscle endurance
- Muscle strength
- Physical performance
- Aging-related cellular biology
- Immune-cell function
If you’re new to the compound, start with our What Is Urolithin A? Complete Guide.
For a deeper look at potential benefits and the limitations of current evidence, see our Urolithin A Benefits Guide.
What Is Resveratrol?
Resveratrol is a naturally occurring polyphenol found in several plants and foods, including:
- Red grapes
- Some berries
- Peanuts
- Wine
Plants produce Resveratrol partly as a protective response to environmental stress.
Resveratrol attracted substantial attention in longevity research because preclinical studies suggested effects on pathways related to:
- Oxidative stress
- Inflammation
- Metabolic signaling
- AMPK
- Sirtuin biology
- Cellular stress responses
However, one of the most important lessons from decades of Resveratrol research is that findings from cellular and animal studies do not always translate directly into meaningful human outcomes.
A 2024 systematic review examining Resveratrol supplementation in older adults included 10 clinical studies and reported potential benefits in selected outcomes, while also emphasizing uncertainty around optimal dose, long-term effects, and interactions. View the systematic review on PubMed.
The Biggest Difference
The original way of describing these compounds is useful, but it needs more nuance.
Urolithin A
Urolithin A research is strongly associated with:
Urolithin A
↓
Mitophagy & Mitochondrial Quality Control
↓
Mitochondrial and Cellular Function
Resveratrol
Resveratrol research is broader and involves multiple pathways:
Resveratrol
↓
Oxidative Stress / Metabolic & Cellular Signaling
↓
Multiple Healthy-Aging Research Pathways
The key difference is therefore not simply:
Urolithin A = mitochondria
Resveratrol = antioxidant
That is too simplistic.
Resveratrol research also involves mitochondrial biology, autophagy-related mechanisms, and energy-sensing pathways. Likewise, Urolithin A research extends beyond a single pathway.
The compounds overlap in some areas of aging biology, but their research histories and proposed mechanisms are different.
Urolithin A vs Resveratrol: Side-by-Side Comparison
|
Feature |
Urolithin A |
Resveratrol |
|---|---|---|
|
Compound Type |
Gut microbiome-derived metabolite |
Plant polyphenol |
|
Common Precursors / Sources |
Ellagitannins and ellagic acid |
Grapes, berries, peanuts |
|
Major Research Focus |
Mitophagy and mitochondrial quality control |
Oxidative stress and cellular/metabolic signaling |
|
Human Clinical Research |
Growing but relatively limited |
Larger and longer research history |
|
Muscle Research |
Several human trials |
Studied, with mixed findings |
|
Mitochondrial Research |
Central research area |
Also investigated |
|
Sirtuin Research |
Not primary defining pathway |
Frequently discussed |
|
Proven Anti-Aging Treatment? |
No |
No |
|
Direct Head-to-Head Trial? |
No established high-quality trial |
No established high-quality trial |
This table highlights why comparing the two solely as “which longevity supplement is better” can be misleading.
Their evidence bases are not identical, and neither has been proven to broadly slow human aging.
What Does Human Research Say About Urolithin A?
Urolithin A has fewer human trials than Resveratrol, but several randomized studies provide useful evidence.
First-in-Human Research
A first-in-human study published in Nature Metabolism evaluated Urolithin A in older adults and investigated its safety, pharmacokinetics, and effects on molecular markers associated with mitochondrial biology.
The researchers reported that Urolithin A was bioavailable and produced biological changes consistent with mitochondrial-related pathways under the conditions studied.
Read the original study: Andreux et al. — Urolithin A First-in-Human Study.
Randomized Trial in Older Adults
A randomized clinical trial involving adults aged 65–90 evaluated 1,000 mg/day of Urolithin A for four months.
Researchers investigated:
- Muscle endurance
- Six-minute walking distance
- ATP production
- Plasma biomarkers
The results were mixed.
Certain muscle endurance measures and plasma biomarkers improved, but the between-group differences for the primary outcomes of six-minute walk distance and maximal ATP production were not statistically significant. (PubMed)
This distinction is important.
It would be inaccurate to describe the trial as demonstrating that Urolithin A improved every aspect of physical function.
Read the study: Liu et al. — Randomized Clinical Trial in Older Adults.
Randomized Trial in Middle-Aged Adults
Another randomized, double-blind, placebo-controlled study evaluated 500 mg/day and 1,000 mg/day for four months in middle-aged adults.
The researchers reported changes in measures including muscle strength and mitochondrial biomarkers, although not every endpoint improved significantly. (PubMed)
Read the study: Singh et al. — Urolithin A in Middle-Aged Adults.
For more detail on the amounts evaluated in clinical research, see our Urolithin A Dosage Guide.
Emerging Human Research
Research continues to expand.
A 2025 randomized, double-blind, placebo-controlled study involving 50 healthy middle-aged adults investigated 1,000 mg/day for four weeks and evaluated immune-cell phenotypes and metabolic changes associated with age-related immune decline. (PubMed)
Read the study: Urolithin A and Age-Related Immune Decline — PubMed.
This is an example of how Urolithin A research is expanding beyond muscle outcomes, although individual studies should not be interpreted as proof of broad anti-aging effects.
What Does Human Research Say About Resveratrol?
Resveratrol has a much larger research history.
That may sound like an automatic advantage, but more studies do not necessarily mean more consistent conclusions.
Human studies have investigated Resveratrol across areas including:
- Cardiovascular biomarkers
- Glucose metabolism
- Cognitive function
- Exercise performance
- Inflammation
- Muscle function
- Metabolic health
- Sirtuin signaling
Results vary substantially depending on:
- Dose
- Study duration
- Participant characteristics
- Health status
- Formulation
- Outcome measured
What Do Systematic Reviews Show?
A 2024 systematic review of Resveratrol supplementation in older adults included 10 studies.
The review reported potentially beneficial findings in selected populations and outcomes, including exercise-related measures and some cognitive outcomes, but it also identified conflicting findings and emphasized the need for more research into dosage, long-term effects, and drug interactions. (PubMed)
Read the review: Effects and Safety of Resveratrol Supplementation in Older Adults.
This is a better representation of the current evidence than saying simply:
“Resveratrol supports longevity.”
That claim is too broad.
What About Resveratrol and SIRT1?
SIRT1 is one of the reasons Resveratrol became so famous in longevity discussions.
Preclinical research has often linked Resveratrol to sirtuin-related mechanisms.
However, human evidence is less straightforward.
A 2025 systematic review and meta-analysis of randomized controlled trials concluded that Resveratrol supplementation did not significantly influence overall human SIRT1 gene expression, protein expression, or serum levels in the pooled analysis, although dose-response analyses suggested the relationship may vary by dosing strategy. (PubMed)
Read the meta-analysis: Impact of Resveratrol Supplementation on Human Sirtuin 1.
This does not mean Resveratrol has no biological activity.
It means that the popular statement:
“Resveratrol activates SIRT1 in humans”
is more definitive than the pooled clinical evidence currently supports.
Which Has Stronger Human Evidence?
This question depends on what we mean by “stronger.”
Resveratrol Has More Human Research
Resveratrol has been studied for much longer and across many more clinical settings.
That gives researchers a broader evidence base.
But the results are highly heterogeneous.
Urolithin A Has a Smaller, More Focused Evidence Base
Urolithin A has fewer human studies, but several randomized trials specifically examine outcomes associated with:
- Mitochondrial biomarkers
- Muscle endurance
- Muscle strength
- Physical performance
That does not mean its evidence is stronger overall.
It means the research program has been more focused around particular biological questions.
The Bottom Line
Resveratrol has more human research overall, while Urolithin A currently has a smaller but increasingly focused human evidence base. Neither has sufficient evidence to be described as a proven human longevity intervention.
Why Some Consumers Are Interested in Urolithin A
People researching Urolithin A are often interested in areas such as:
Mitochondrial Biology
Mitochondrial quality control is an important area of aging research.
Muscle Function
Human trials have investigated measures of muscle endurance, strength, and physical performance.
Mitophagy
Urolithin A is frequently studied in relation to cellular pathways involved in mitochondrial quality control.
Healthy Aging Research
Interest has expanded as more human trials have been published.
For a full evidence review, read Urolithin A Benefits: What Current Research Shows.
Why Some Consumers Are Interested in Resveratrol
Resveratrol has remained popular because of its long history in nutrition and aging research.
Common research areas include:
Polyphenol Biology
Resveratrol is one of the most intensively studied plant-derived polyphenols.
Oxidative Stress
Its interaction with oxidative and inflammatory pathways has been studied extensively in laboratory and clinical research.
Metabolic Signaling
Researchers have investigated pathways involving AMPK, sirtuins, glucose regulation, and cellular energy sensing.
Healthy Aging Research
Resveratrol remains prominent in aging research despite inconsistent clinical outcomes.
Which Supplement Is Better?
There is no evidence-based answer establishing one as universally better.
The original “Choose Urolithin A if…” and “Choose Resveratrol if…” framework is useful for understanding research focus, but it should not be interpreted as a personalized medical recommendation.
A more accurate comparison is:
Urolithin A May Be More Relevant to Research Focused on:
- Mitophagy
- Mitochondrial quality control
- Muscle endurance
- Mitochondrial biomarkers
Resveratrol May Be More Relevant to Research Focused on:
- Polyphenol biology
- Oxidative stress
- Metabolic signaling
- Sirtuin-related mechanisms
But these categories overlap.
And neither compound has been proven to broadly extend human lifespan or prevent age-related disease.
Can You Take Urolithin A and Resveratrol Together?
This is one of the most important sections to phrase carefully.
Urolithin A and Resveratrol affect different but partially overlapping areas of cellular biology.
However, there is currently insufficient high-quality human evidence showing that combining Urolithin A and Resveratrol produces better outcomes than using either compound alone.
Direct randomized trials comparing:
- Urolithin A alone
- Resveratrol alone
- Urolithin A + Resveratrol
- Placebo
are not part of the established clinical evidence base reviewed here.
Therefore:
Theoretical complementarity should not be interpreted as proven clinical synergy.
People taking medications, managing a medical condition, or considering multiple supplements should discuss their supplement routine with an appropriately qualified healthcare professional.
Urolithin A vs NMN vs Resveratrol
These three ingredients are frequently grouped together in longevity discussions, but they should not be treated as interchangeable.
NMN
NMN is a precursor involved in NAD+ metabolism.
NMN
↓
NAD+ Metabolism
↓
Cellular Energy Processes
Urolithin A
Urolithin A
↓
Mitophagy
↓
Mitochondrial Quality Control
Resveratrol
Resveratrol
↓
Multiple Cellular Signaling Pathways
↓
Metabolic & Oxidative Stress Research
These simplified diagrams illustrate research emphasis rather than proven clinical outcomes.
If you’re specifically comparing NAD+ precursors with Urolithin A, read our NMN and Urolithin A guide.
Building a Healthy Aging Routine
Healthy aging should not be reduced to a supplement stack.
Some of the most established foundations remain:
Exercise
Regular physical activity supports cardiovascular fitness, muscle function, mobility, and metabolic health.
Sleep
Adequate, consistent sleep is an important component of physical and cognitive health.
Nutrition
A varied diet rich in minimally processed foods, fruits, vegetables, protein, fiber, and healthy fats provides a stronger foundation than relying on isolated supplements.
Stress Management
Long-term stress management, social connection, and recovery habits also contribute to overall well-being.
Supplements
Supplements may be considered as one part of a broader wellness strategy, but they should not replace established lifestyle practices or medical care.
Safety and Evidence Limitations
Neither Urolithin A nor Resveratrol should be discussed as if its long-term effects are completely understood.
Urolithin A
Published human trials provide short- and medium-term safety information under specific research conditions, but the overall evidence base remains relatively small.
For more detail, see our Urolithin A Side Effects and Safety Guide.
Resveratrol
Resveratrol has been evaluated across many human studies, but tolerability can depend on dose and population. Systematic reviews continue to call for better evidence on long-term dosing, safety, and drug interactions. (PubMed)
People who are pregnant or breastfeeding, take prescription medications, have a diagnosed medical condition, or are preparing for surgery should discuss supplement use with a healthcare professional.
Our Perspective
At Celnovix, we believe the most useful way to compare Urolithin A and Resveratrol is not to declare a winner.
Instead, the goal should be to understand:
- What each compound is
- Which biological pathways researchers are studying
- What human trials have actually shown
- Which findings remain uncertain
- Where marketing claims go beyond the evidence
Urolithin A currently has an increasingly focused body of human research around mitochondrial and muscle-related outcomes.
Resveratrol has a larger and longer clinical research history, but the overall evidence remains heterogeneous.
Neither should be presented as a proven anti-aging therapy.
Healthy aging remains a much broader process involving physical activity, nutrition, sleep, medical care, and long-term lifestyle habits.
Frequently Asked Questions
Is Urolithin A better than Resveratrol?
Current human evidence does not establish Urolithin A as universally better than Resveratrol.
The two compounds have different research histories and biological focuses. Urolithin A research is strongly associated with mitochondrial quality control and mitophagy, while Resveratrol research spans oxidative stress, metabolic signaling, sirtuin biology, and other pathways.
Does Urolithin A have better human evidence than Resveratrol?
Not necessarily.
Resveratrol has substantially more human research overall, but the results are inconsistent across different populations and outcomes.
Urolithin A has fewer studies, although several randomized human trials have investigated mitochondrial biomarkers, muscle endurance, and physical performance.
Can I take Urolithin A and Resveratrol together?
There is currently insufficient high-quality human evidence showing that the combination provides better clinical outcomes than either compound alone.
The fact that the compounds influence different pathways does not prove that combining them produces synergy.
Is Resveratrol the same as Urolithin A?
No.
Resveratrol is a plant-derived polyphenol, while Urolithin A is a metabolite produced through gut microbial conversion of ellagitannin- and ellagic-acid-containing compounds.
Which is better for mitochondrial health?
Urolithin A has been studied specifically in relation to mitophagy and mitochondrial biomarkers.
Resveratrol also influences pathways associated with mitochondrial and metabolic biology, so it would be inaccurate to describe mitochondrial effects as unique to Urolithin A.
There is no established head-to-head clinical trial proving one is superior for mitochondrial health.
Which is better for healthy aging?
Neither has been proven to broadly slow human aging.
Both are being studied in areas relevant to aging biology, but healthy aging cannot be reduced to a single supplement.
Does Resveratrol activate SIRT1?
Preclinical literature has linked Resveratrol with SIRT1-related pathways, but human evidence is more complicated.
A 2025 meta-analysis of randomized controlled trials found no significant overall effect on human SIRT1 measures, although dose-response relationships may vary. View the meta-analysis.
Can I take NMN, Urolithin A and Resveratrol together?
There is not enough high-quality randomized human evidence to conclude that combining all three produces superior health or longevity outcomes.
People considering multiple supplements—particularly those using medication or managing health conditions—should consult an appropriately qualified healthcare professional.
Final Answer
So, Urolithin A vs Resveratrol: which one is better?
Current evidence does not support a universal winner.
Urolithin A has a growing body of human research focused particularly on mitochondrial quality control, mitophagy, muscle endurance, and physical function.
Resveratrol has a much larger research history across metabolic, cardiovascular, inflammatory, and cellular-signaling pathways, but human outcomes remain inconsistent.
The most scientifically defensible conclusion is:
They are different compounds with different evidence bases—not interchangeable products and not proven anti-aging therapies.
Rather than choosing based on marketing claims, evaluate the actual human evidence, study population, outcome measured, safety considerations, and your individual health context.
Continue Reading
Explore more evidence-based Celnovix guides:
- What Is Urolithin A?
- Urolithin A Benefits
- Urolithin A Dosage Guide
- Urolithin A Side Effects
- Urolithin A vs CoQ10
- Can You Take NMN and Urolithin A Together?
References
-
Andreux PA, et al. The mitophagy activator urolithin A is safe and induces a molecular signature of improved mitochondrial and cellular health in humans.
PubMed -
Liu S, et al. Effect of Urolithin A Supplementation on Muscle Endurance and Mitochondrial Health in Older Adults: A Randomized Clinical Trial.
PubMed -
Singh A, et al. Urolithin A improves muscle strength, exercise performance, and biomarkers of mitochondrial health in a randomized trial in middle-aged adults.
PubMed -
Singh A, et al. Direct supplementation with Urolithin A overcomes limitations of dietary exposure and gut microbiome variability.
PubMed -
Denk D, et al. Effect of the mitophagy inducer urolithin A on age-related immune decline: a randomized, placebo-controlled trial.
PubMed -
Yadegar S, et al. Effects and safety of resveratrol supplementation in older adults: a systematic review.
PubMed -
Mansouri F, et al. Impact of Resveratrol Supplementation on Human Sirtuin 1: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
PubMed
Evidence Transparency Note
Some important Urolithin A clinical studies have financial relationships with companies involved in commercial Urolithin A development.
Industry funding does not automatically invalidate research. However, funding sources and conflicts of interest are relevant when interpreting an evidence base.
Research should therefore be evaluated using:
- Study design
- Randomization and blinding
- Sample size
- Participant characteristics
- Primary versus secondary endpoints
- Statistical significance
- Independent replication
- Funding disclosures
- Conflict-of-interest statements
Medical & Editorial Disclaimer
This article is provided for general educational purposes only and does not constitute medical advice, diagnosis, treatment, or an individualized supplement recommendation.
Research findings discussed here describe specific study populations, doses, durations, and experimental protocols. They should not automatically be generalized to every individual.
People who are pregnant or breastfeeding, take prescription medication, have a diagnosed medical condition, are preparing for surgery, or are considering multiple dietary supplements should discuss their situation with an appropriately qualified healthcare professional.
Article reviewed: August 2026
Evidence standard: Human randomized trials, systematic reviews, meta-analyses, and primary biomedical sources were prioritized. Preclinical findings are not presented as proof of human clinical benefit.
